Lv7
4265 积分 2021-06-09 加入
Fibrosis: cross-organ biology and pathways to development of innovative drugs
12小时前
待确认
Discovery of an Oxycyclohexyl Acid Lysophosphatidic Acid Receptor 1 (LPA1) Antagonist BMS-986278 for the Treatment of Pulmonary Fibrotic Diseases
7天前
已完结
Turning Off STAT6 with a Targeted Degrader
14天前
已完结
Thirty years of NRF2: advances and therapeutic challenges
14天前
已完结
Turning Off STAT6 with a Targeted Degrader
25天前
已完结
Molecular insights into SMARCA2 degradation in SMARCA4-mutant lung cancers
27天前
已完结
Voltage-gated sodium channels in excitable cells as drug targets
29天前
已完结
MYC in cancer: from undruggable target to clinical trials
29天前
已完结
Novel Glucagon Receptor Antagonists with Improved Selectivity over the Glucose-Dependent Insulinotropic Polypeptide Receptor
1个月前
已完结
Screening Hit to Clinical Candidate: Discovery of BMS-963272, a Potent, Selective MGAT2 Inhibitor for the Treatment of Metabolic Disorders
1个月前
已完结
皖公网安备34019202002308
